[1]
|
Global Alliance for Rabies Control. World rabies day. 2025. https://rabiesalliance.org/world-rabies-day. [2025-8-25]. |
[2]
|
Yin WW, Fu ZF, Gao GF. Progress and prospects of dog-mediated rabies elimination in China. China CDC Wkly 2021;3(39):831 − 4. https://doi.org/10.46234/ccdcw2021.205. |
[3]
|
Sun S, Ma JH, Xu Y, Zeng Z, Liu J, Hada, et al. Surveillance and Analysis of Animal Rabies — China, 2004–2024. China CDC Wkly 2025;7(39):1236 − 41. https://doi.org/10.46234/ccdcw2025.208. |
[4]
|
Ma YX, Fang ZX, Tao XY, Liu SQ, Liu Q, Zhang MH, et al. Efficacy evaluation of virus clearance of SYN023 in a murine rabies model-China, 2025. China CDC Wkly 2025;7(39):1242 − 6 https://doi.org/10.46234/ccdcw2025.209. |
[5]
|
Chen YJ, Wei MW, Xu XT, Shi YF, Zhang SX, Wang CH, et al. Active surveillance on safety and compliance of freeze-dried human rabies vaccine (Vero cell) —Jiangsu Province, China, 2023-2024. China CDC Wkly 2025;7(39):1247 − 52 https://doi.org/10.46234/ccdcw2025.210. |
[6]
|
Li H, Wei j, Zhan ZQ, Tang JF, Wang W, Zhou SW, et al. Metagenomic next-generation sequencing unmasks atypical rabies — Guangxi Zhuang Autonomous Region, China, 2024. China CDC Wkly 2025;7(39):1253 − 8 https://doi.org/10.46234/ccdcw2025.211. |
[7]
|
Chen QJ, Yin WW, Zhu ZG, Wang CL. The advantages of anti-rabies monoclonal antibodies in post-exposure prophylaxis-worldwide, 2016-2025. China CDC Wkly 2025;7(39):1259 − 63 https://doi.org/10.46234/ccdcw2025.212. |